Breaking News Instant updates and real-time market news.

SAGE

Sage Therapeutics

$91.90

2.11 (2.35%)

06:19
12/07/17
12/07
06:19
12/07/17
06:19

Sage Therapeutics up 52% after 'positive' results from Phase 2 trial of SAGE-217

In pre-market trading, shares are up 52.34% to $140.00.

SAGE Sage Therapeutics
$91.90

2.11 (2.35%)

11/10/17
NEED
11/10/17
NO CHANGE
Target $100
NEED
Buy
Sage Therapeutics price target raised to $100 from $86 at Needham
Needham analyst Danielle Brill raised her price target on Sage Therapeutics to $100 and kept her Buy rating. Brill cites the company's IV brexanolone Phase 3 trials in moderate and severe postpartum depression achieving primary efficacy endpoints, saying that while she had modest expectations for overall commercial opportunity w/ brexanolone, the drug does highlight an unmed need as the first treatment approved for PPD. The analyst adds that there is also significant upside opportunity for Sage shares w/ Phase 2 MDD data reporting expected out by year-end.
11/15/17
RHCO
11/15/17
NO CHANGE
Target $116
RHCO
Buy
Sage Therapeutics price target raised to $116 from $82 at SunTrust
SunTrust analyst Edward Nash raised his price target on Sage Therapeutics to $116 based on the recent positive top-line data from both Phase III trials for brexanolone in post-partum depression. Nash says he has increased his probability of success estimate for the treatment to 80% from 70%, with the remaining 20% based on regulatory risk. The analyst also adjusted his projections for the drug efficacy in Major Depressive Disorder, keeping his Buy rating on Sage Therapeutics.
11/17/17
BMOC
11/17/17
NO CHANGE
Target $112
BMOC
Outperform
Sage Therapeutics price target raised to $112 from $80 at BMO Capital
BMO Capital analyst Gary Nachman raised his price target for Sage Therapeutics to $112 saying he received "very positive" feedback from two leading psychiatrists on the brexanolone Phase 3 data in both severe and moderate postpartum depression. The shares closed yesterday up 20c to $85.67. The physicians are "very impressed" by the rapid onset and good safety profile for brexanolone and expect to use the drug a lot, Nachman tells investors in a research note. The psychiatrists also expressed their belief in a high probability of success for the upcoming SAGE-217 data in postpartum depression and major depressive disorder, the analyst adds. He sees a good risk/reward into those catalysts at current share levels. Nachman reiterates an Outperform rating on Sage.
11/27/17
RBCM
11/27/17
NO CHANGE
Target $137
RBCM
Outperform
Sage Therapeutics price target lowered to $137 from $145 at RBC Capital
RBC Capital analyst Brian Abrahams lowered his price target on Sage Therapeutics to $137 from $145, modelling a 40% probability of success and the possibility of more non-responders in the Phase 2B SAGE-217 for major depressive disorder - MDD - treatment. Abrahams keeps Outperform rating, saying the risk-reward profile is still attractive given the likelihood of "many additional shots on goal even if MDD fails", as negative outcome would not necessarily impact the overall prospects of the oral program in post-partum depression.

TODAY'S FREE FLY STORIES

SPY

SPDR S&P 500 ETF Trust

$272.86

0.27 (0.10%)

, SPX

S&P 500

$0.00

(0.00%)

10:36
11/13/18
11/13
10:36
11/13/18
10:36
Periodicals
Trump considering replacements for chief of staff, DHS secretary, ABC News says »

President Donald Trump is…

SPY

SPDR S&P 500 ETF Trust

$272.86

0.27 (0.10%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$43.97

-0.66 (-1.48%)

, SWI

SolarWinds

$14.94

0.19 (1.29%)

10:35
11/13/18
11/13
10:35
11/13/18
10:35
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

AERI

Aerie Pharmaceuticals

$43.97

-0.66 (-1.48%)

SWI

SolarWinds

$14.94

0.19 (1.29%)

PHAS

PhaseBio

$5.03

(0.00%)

LOGC

LogicBio Therapeutics

$13.87

(0.00%)

CREE

Cree

$42.80

1.27 (3.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 26

    Nov

  • 14

    Mar

LITE

Lumentum

$40.92

3.415 (9.11%)

, BBY

Best Buy

$67.28

0.14 (0.21%)

10:35
11/13/18
11/13
10:35
11/13/18
10:35
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

LITE

Lumentum

$40.92

3.415 (9.11%)

BBY

Best Buy

$67.28

0.14 (0.21%)

PRGO

Perrigo

$65.43

-0.11 (-0.17%)

SBRA

Sabra Health Care

$20.84

-0.28 (-1.33%)

INFN

Infinera

$4.40

-0.15 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

VERI

Veritone

$6.78

-0.11 (-1.60%)

, NVDA

Nvidia

$196.71

7.34 (3.88%)

10:35
11/13/18
11/13
10:35
11/13/18
10:35
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

VERI

Veritone

$6.78

-0.11 (-1.60%)

NVDA

Nvidia

$196.71

7.34 (3.88%)

XLNX

Xilinx

$84.02

1.69 (2.05%)

KOP

Koppers Holdings

$21.08

0.88 (4.36%)

SWN

Southwestern Energy

$6.08

0.28 (4.83%)

SAIL

SailPoint

$25.16

0.86 (3.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 16

    Nov

  • 19

    Nov

  • 20

    Nov

  • 26

    Nov

  • 26

    Nov

  • 27

    Nov

  • 10

    Dec

  • 09

    Jan

10:35
11/13/18
11/13
10:35
11/13/18
10:35
General news
Treasury Action: yields remained pinned lower »

Treasury Action: yields…

10:35
11/13/18
11/13
10:35
11/13/18
10:35
General news
U.S. Retail Sales Face Upside Risks in October: »

U.S. Retail Sales Face…

CBTX

CBTX

$33.14

(0.00%)

10:33
11/13/18
11/13
10:33
11/13/18
10:33
Conference/Events
CBTX management to meet with Stephens »

Group Luncheon Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

XBI

SPDR S&P BIOTECH

$78.80

1.13 (1.45%)

10:30
11/13/18
11/13
10:30
11/13/18
10:30
Options
Second day of big spreads in SPDR Biotech ETF »

Second day of big spreads…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEP

Korea Electric Power

$12.00

0.06 (0.50%)

10:29
11/13/18
11/13
10:29
11/13/18
10:29
Upgrade
Korea Electric Power rating change  »

Korea Electric Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIF

Tiffany

$109.48

0.44 (0.40%)

, SIG

Signet Jewelers

$56.30

0.96 (1.73%)

10:27
11/13/18
11/13
10:27
11/13/18
10:27
Periodicals
Alrosa said to cut low-end diamond prices by as much as 10%, Bloomberg reports »

Retail jewelers that may…

TIF

Tiffany

$109.48

0.44 (0.40%)

SIG

Signet Jewelers

$56.30

0.96 (1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

TSLA

Tesla

$337.76

6.61 (2.00%)

10:24
11/13/18
11/13
10:24
11/13/18
10:24
Periodicals
Tesla loses legal executive with regulatory experience, Bloomberg reports »

Phil Rothenberg, an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

  • 13

    Dec

SRCL

Stericycle

$47.11

0.07 (0.15%)

10:23
11/13/18
11/13
10:23
11/13/18
10:23
Recommendations
Stericycle analyst commentary  »

Stericycle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$177.04

-2.47 (-1.38%)

10:21
11/13/18
11/13
10:21
11/13/18
10:21
Technical Analysis
Technical Take: Home Depot falls after earnings news »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ROST

Ross Stores

$100.34

-1.42 (-1.40%)

10:20
11/13/18
11/13
10:20
11/13/18
10:20
Options
Earnings hedge in Ross Stores »

Earnings hedge in Ross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

10:20
11/13/18
11/13
10:20
11/13/18
10:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

HD

Home Depot

$177.27

-2.24 (-1.25%)

10:19
11/13/18
11/13
10:19
11/13/18
10:19
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

T

AT&T

$30.85

0.05 (0.16%)

10:19
11/13/18
11/13
10:19
11/13/18
10:19
OnTheFly
Trump Effect: CNN suing White House over Jim Acosta’s revoked press credentials »

CNN has announced via…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$194.00

4.63 (2.44%)

10:18
11/13/18
11/13
10:18
11/13/18
10:18
Technical Analysis
Technical Take: Nvidia bounces off lows »

The shares hit an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 26

    Nov

  • 10

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
11/13/18
11/13
10:17
11/13/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAG

Amag Pharmaceuticals

$18.04

0.07 (0.39%)

10:16
11/13/18
11/13
10:16
11/13/18
10:16
Recommendations
Amag Pharmaceuticals analyst commentary  »

Piper remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

  • 23

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
11/13/18
11/13
10:16
11/13/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAG

Amag Pharmaceuticals

$18.04

0.07 (0.39%)

10:12
11/13/18
11/13
10:12
11/13/18
10:12
Hot Stocks
FDA asks Amag for additional Vyleesi data, January panel meeting on hold »

Amag Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

  • 23

    Mar

AAL

American Airlines

$37.72

0.85 (2.31%)

10:10
11/13/18
11/13
10:10
11/13/18
10:10
Options
American Airlines attracts short-term call buying as shares advance »

American Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:02
11/13/18
11/13
10:02
11/13/18
10:02
Conference/Events
Washington Association of Money Managers to hold a meeting »

Tapan Gandhi, Principal…

GEOS

Geospace

$14.58

(0.00%)

10:01
11/13/18
11/13
10:01
11/13/18
10:01
Hot Stocks
Geospace announces acquisition of OptoSeis fiber optic technology »

Geospace Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.